Mental Health Awareness Month: Innovative Ways Therapy Is Reaching Workers and Families
Explore how telehealth, text therapy, AI tools, digital therapeutics, crisis texting, and virtual reality are changing access to mental health care for workers and families.
A Union-Led Healthcare Innovation: How 32BJ and Northwell Direct Are Rewriting the Cost Model
For unions and Taft-Hartley funds, the 32BJ-Northwell Direct agreement offers a possible blueprint. It shows that labor can be more than a defender of benefits; it can be an architect of better healthcare purchasing.
GLP-1 Medication Semaglutide Shows Promise in Alcohol Use Disorder Study
A new randomized controlled trial published in The Lancet reports that once-weekly semaglutide injections reduced heavy drinking days among adults with alcohol use disorder and obesity when used alongside cognitive behavioral therapy.
Prime Therapeutics’ leading research shows only 1 in 12 remain on a GLP-1 drug for obesity at three years
Findings also show improved persistence with high-potency, obesity-approved GLP-1 products Eagan, Minn. – June 25, 2025 – Only 8% of individuals (or 1 in 12) initiating a glucagon-like peptide-1 (GLP-1) agonist drug for obesity without diabetes continued to do so at three years, according to the latest real-world research from pharmacy solutions partner Prime Therapeutics…
Union Growth Continues
Washington, D.C. – Union representation grew by 463,000 in 2025 according to new data released by U.S. Bureau of Labor Statistics shows. The total number of workers represented by union contracts is now 16.5 million with 11.2% of all wage and salary workers in the United States now covered under union contracts. This is the highest in…